本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNTech SE

104.68
+2.872.82%
盘前106.371.69+1.61%05:48 EDT
成交量:124.65万
成交额:1.30亿
市值:251.20亿
市盈率:-36.50
高:105.20
开:101.24
低:101.24
收:101.81
数据加载中...
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/03/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/22

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/26

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/10

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/10

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/10

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/30

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals